Addiction

MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation

SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% weight loss and...

Hazelden Betty Ford and Sigma Chi Launch Partnership to Expand Access and Inspire a New Standard for Behavioral Health Support

Initiative reduces stigma, streamlines access to care, and provides financial support; offering a model for other organizations nationwide.Center City, Minnesota--(Newsfile...

error: Content is protected !!